Peter Brenders, general manager of Sanofi Genzyme Canada, highlights the strategic significance of the Canadian affiliate, which has seen double-digit growth every quarter for the past five and a half years; the challenges it faces within Canada’s market access environment; and the personal motivation driving him after three decades in the healthcare and life sciences space.
Peter, with a new head, Bill Sibold, heading up Sanofi Genzyme as of July 2017, and the larger Sanofi reorganization led by CEO Oliver Brandicourt in 2016, what has this meant for the Canadian affiliate over the past few years?
"At Sanofi Genzyme, we do not see our activities as mere transactions, but an investment in working with the healthcare systems and patients within Canada."
